Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I certainly think something is going to happen pretty soon.
Was wondering why 10q was delayed for 15 days, reason I think news is coming
Thanks buck for posting this link, interesting information and thoughts of Dr Chain.
There clearly is along way to go before we find a cure for this terrible disease, but clearly Bapi is not over and done with. I think there is a clear understanding that treatment needs to start much earlier, and Bapi clearly shows the ability to clear what is thought to be the main cause.
Nice to hear that there is an ongoing phase 2 trial still underway.
Would not be surprised if we see some more news tomorrow or thursday. Last few weeks news on either of these days, just think more is coming.
We will see.
Very surprised at the lack of volume today. Another positive press release.
Just need that press release that provides a little cash, like milestone payment. Then we will see a spike in the price.
New presentation on adxs website.
At 24 mins 45 secs Rothman stated that approx 40 patients in follow up after 1 year. That is huge news for this patient population
Would love to know the financial part of this deal. Ilns I expect must have got some sort of financial payment for this.
I actually think there is something going on behind the scenes re finances. No real reason to delay filing, not much been going on that has been disclosed.
The thing with ilns has always been risk reward. One day you coils wake up and find ilns has gone, recent news suggests that this is not going to happen anytime soon.
One day you could wake up to find that the share price has gone into orbit, that's the ilns investment. All about risk reward.
Thing about today was that volume was only 344,753, much lower than the last few days which saw millions bought.
Very little selling today, which makes me positive for next week. Those that bought want to hold.
We will agree on something, you took a very big risk
Sub,
So what are you a shorter or a buyer of adxs
Nice 1 million shares bought in last 6 mins.
Certainly interesting move over last few trading days. Would like to see a little more volume which may confirm what you are saying
They also paid Numoda more than what the current share price is, and all shares have been given to Socius already, just adjustment in shares to be given if price stays below 8.4 cents by end of next week. That's reason why price is being kept low.
Hey batski, what's your take on these filings, to be honest don't understand them myself
It's certainly not over for bapi and ilns.
Shareholder presentation slides available on adxs website.
Everyone should read some of the stories regarding patients, very moving.
http://www.advaxis.com/news-and-ceo-blog/events-presentations/
Lots of bashing going on, on the yahoo message board. Insiders have bought more and are still holding, good reason to hold or add at these levels.
Anyone know what happened re the presentation today. Did more present, no one seems to know
Bio,
I hope you are right, I hate to see big pharma try and squash small biotechs just because they think they can.
Just wondering why you are so sure of your comments
You have to ask why though. If you read the licensing agreements it clearly states on receiving US patent.
There is more to this, I think we will find out that drug works and they don't want to pay the 5% royalties. I think you could find a much larger pharma coming in and buying ilns if results show some promise, and then going after these large pharma for not paying up.
Strange though that buys were up after news.
Can't see how they can hold back the milestone payment. Clearly states that payment is due on issuance of US patent.
Clearly trying to starve ilns of cash, trying to get ilns very cheap. Maybe drug does work and they don't want to pay the 5% royalties.
Looks like adxs may well be taking the cervical vaccine as far as they can on their own. Requesting shareholder approval to increase number of shares.
Zino,
At the moment ilns does not have the n- terminus patent only the c- terminus which was granted recently. Ilns still waiting to hear about n- terminus.
Bapi is based on the n- terminus discovery by ilns, ilns gets patent and bapi is shown to work then ilns will receive royalties of 5% on all sales of bapi.
Ilns already has patent for n- terminus in other parts of the world.
I think the fact that ilns is still waiting for n- terminus patent maybe the reason. I think we may well get news on that soon which I expect to be positive. This should have massive impact on share price, and if bapi results show some promise which I expect in certain patients, then ilns share price could easily be in the dollar range we will see.
Could begin to see a real run up, looks like results could be out mid August if not earlier
Results due on potential 'wonder drug'
Elan, which may be on the cusp of the biggest drug discovery ever unveiled by an Irish company, may be taken over by its partner Johnson & Johnson, if crucial trials work.
Johnson & Johnson already owns 18.4 per cent of €6.9bn-valued Elan, following a complex deal which sees the US drug giant fund much of the research costs of its potential Alzheimer's wonder drug.
Coming weeks will see key milestones for Elan and its partners as they await the results of trials before seeking to have the drug cleared by regulators.
Chairman Bob Ingram has hailed the upcoming results as "potentially of transformational significance for Elan".
If the drug is found to work and can be commercially produced, it has the potential to become a blockbuster drug with sales of up to $10bn per year, which would be a gamechanger for Elan, which was set up to develop nicotine patches in Athlone by entrepreneur Don Panoz in 1969. Elan was the first Irish company to list on Nasdaq, when it floated in 1982.
Last week, RBC analyst Michael Yee said top-line findings of two US studies may be released in the second week of August. Another major study into the drug could be completed in about three weeks time. Finally, Elan's research partner Johnson & Johnson and Pfizer are said to be preparing information for the European Federation of Neurological Societies meeting on September 8.
"Our interest in bapineuzumab [the drug] is financial and because of this we are unable to comment on timelines and prospects," according to a spokeswoman.
Johnson & Johnson has been widely linked with a bid for Elan since the start of the year, with Elan's share price ticking up noticeably. Shares have risen more than 40 per cent over the past year.
Under a standstill agreement written into the 2009 deal between Johnson & Johnson and Elan, the US pharma behemoth is not permitted to make a buyout approach until 2014.
However, it is understood that a majority Elan shareholder vote would be able to overrule this agreement.
Elan has a 25 per cent stake in the Alzheimer's programme. The Irish company developed the secret sauce part of bapineuzumab with Wyeth, before Pfizer took over the US company.
Johnson & Johnson and Pfizer are now fronting the research programme.
Elan boss Kelly Martin, who was due to leave the company, at the start of the year, agreed to stay on until after the seminal drug trial results.
The hype surrounding Elan and the potential "wonder drug" may be familiar to shareholders, who have seen the company's share price soar at various times over the past decade on the expectation of a major medical breakthrough. Those investors have nursed heavy losses and must be desperately hoping that, this time, Elan is on to a real winner.
- Nick Webb
No doubt this is bt/yogi, he has destroyed the yahoo message board. Go away bt you have nothing useful to say.
Suprise increase in volume today. Would love to see news soon re N-Terminus.
Can't find anynews as to why sudden increase in volume.
I believe that Moore said that next India update would be sometime in the fall. Not sure re CIN, but could be around December.
Okay I was wrong
I think we may get some news tomorrow, just a feeling.
Would be a good time to announce something new as presenting at 2 different conferences. We will see. Probably wrong but you never know.
I think we go back to 15 cents very quickly. News today is a real endorsement by Numoda to what adxs is doing. The fact that Numoda who are running adxs trials in India and CIN in US were willing to accept shares at 40% above current share price indicates how confident they are. Also very strange that adxs have a 20 day clause to buy them back at 15 cents. You never know maybe they have some money on the way.
They will receive it, part of the licensing agreement.
I still believe that adxs can get funds from Numoda if they wanted. That's to say that they have not already.
Should see if this is the case when results are reported, which should be very soon.
Remember that Numoda had on their site for about 24 hrs that they had funded adxs, which was suddenly removed......big question is why?
Wonder how long it will take to clear 10 cents. Seem all buys this morning. I think when we do we will see price move up through quite quickly.
With 2 million milestone payment coming any day, t the current time I don't see any need to finance. This should get us to Bapineuzumab results and beyond. Should get more patent news by then which if positive should provide more milestone payments.
Bapineuzumab patent is the big one, would hope to get an update from Chain re this. Chain normally issues a shareholder letter when results are announced, so may see this in the morning
Bapineuzumab patent is the big one, would hope to get an update from Chain re this. Chain normally issues a shareholder letter when results are announced, so may see this in the morning
It says re 1 month at the top of the filing, then 9 months at the bottom. I was surprised to see cash burn so quick, but legal fees re patents must be costing ilns a lot at the moment
I think you forgot to mention the 2 million ilns will get as milestone payment, so should not need any money for 6 to 9 months at the earliest.